PFBT
OCUL icon

Parkside Financial Bank & Trust’s Ocular Therapeutix OCUL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09K Hold
129
– – ﹤0.01% 2329
2025
Q4 		$1.57K Hold
129
– – ﹤0.01% 2187
2025
Q3 		$1.51K Hold
129
– – ﹤0.01% 2122
2025
Q2 		$1.2K Buy
+129
New +$1.01K ﹤0.01% 2193

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Parkside Financial Bank & Trust's OCUL Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Ocular Therapeutix (OCUL) position steady in Q1 2026 at 129 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2329.

Parkside Financial Bank & Trust first reported a position in OCUL in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.57K in Q4 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Parkside Financial Bank & Trust held 129 shares of Ocular Therapeutix worth $1.09K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Ocular Therapeutix share count unchanged in Q1 2026.
  • Ocular Therapeutix made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2329 holding.
  • Parkside Financial Bank & Trust first reported a position in Ocular Therapeutix in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Ocular Therapeutix position peaked at $1.57K in Q4 2025.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.